Lecture 10: Pre-mRNA Processing in Eukaryotes Flashcards
1
Q
What is capping and where does it take place?
A
- Addition of cap structure at 5’ end
- Linked to 5’ mRNA by 5’-5’
triphosphate bridge - Enzymes required:
a. 5’ triphosphatase
b. guanylyl transferase
c. 7-methyl transferase - Once cap structure made, will be bound
to by “cap-binding complex”
a. gives ability to leave cell
b. and take part in translation
c. promote correct splicing
2
Q
What is polyadenylation and where does it take place?
A
- 3’ end
- poly-A tail
- Anything transcribed past the poly-A
site is degraded - Can be used for mRNA purification
- mechanism
a. poly-A signal; poly-A cut site down
stream
b. 3’ processing complex binds and
cleaves
c. ~10 A’s added (potentially hundreds)
3
Q
How is splice sites recognised?
A
- 5’ = Splice junction donor
a. just inside intron - 3’ = Spice junction acceptor
a. just outside intron - ONLY ONE 100% CONSERVED
CONSENSUS SEQUENCE…
a. DNA = GT… …AG
b. RNA = GU… …AG
c. branch point = A residue
4
Q
How does splicing take place?
A
- “Lariat Formation”
- attack of the “branch point” 2’ A-residue to the splice junction donor (5’)
- OH on 3’ of exon attacks 5’ mRNA exon
- exposes an OH group of the lariat loop
which gets degraded
5
Q
What is responsible for splicing?
A
1. Spliceosome - five U-rich small nuclear RNAs (snRNAs) designated: a. U1 b. U2 c. U4 d. U5 e. U6 2. (Form complexes with 6-10 proteins each) 3. U2 pairs in a way that the 'A branch point' sticks out -allows first transesterification reaction
6
Q
What is the order of events of splicing?
A
- U1 and U2 bind
2. U4, U5, and U6
7
Q
What is alternative splicing
A
- Ability of a single pre-mRNA to form
different products
a. 35-59% of human genes show
variably spliced products
8
Q
How is alternative splicing regulated?
A
- Negative factors: prevent U1 or U2
binding OR block spliceosome assembly
after U1/U2 - Positive factors: enhance spliceosome
assembly at sites that are otherwise
poorly recognised
9
Q
What is the role of RNAP2 C-terminal domain?
A
1. Regulates timing of splicing, capping, poly-adenylation 2. 52 repeats of YSPTSPS 3. Pol 2A unphosphorylated = initiation 4. Pol 2O phosphorylated = elongation
5. Capping = Phosphorylation of serine 5; capping enzyme binding 6. Splicing = phosphorylation of serine 2; splicing factors bind 7. Poly A formation
10
Q
How does mRNA export take place?
A
- Nuclear exporter:
a. heterodimeric RNA binding protein
b. associates with the FG (phenylalanine-
glycine) repeats of nucleoporin
proteins that line nuclear pore
c. mRNA exporter recycles back to
nucleus
11
Q
How and why does mRNA maintain stability
A
- 5’ cap:
a. aids mRNA nuclear export
b. protects 5’ - 3’ exonuclease
degradation in cytoplasm
c. enhances transateability - Poly-A tail
a. all of above - 3’UTR:
a. contains regulatory elements - VAST VARIATION ON STABILITY
a. <30 mins to tens of hours
b. short lived often regulatory proteins
c. long lived often structural/metabolic
enzymes
12
Q
How are mRNAs degraded?
A
- many short love mRNAs contain AU-rich elements in 3’UTRs
- AUUUA elements can bind specific proteins that interact with the deadenylating enzyme and the exosome, promoting rapid mRNA turnover
13
Q
What are the 3 pathways for mRNA degradation?
A
1. Decapping pathway (deadenylation- independent) a. decapping b. exonucleolytic activity 2. Deadenylation-dependent a. Poly-A shortening b. decapping OR exonucleolytic decay c. if dacapped, then exonucleolytic decay 3. Endonucleolytic pathway a. endonucleolytic cleavage b. exonucleolytic decay